home / stock / nrc / nrc news


NRC News and Press, National Research Corporation From 12/18/23

Stock Information

Company Name: National Research Corporation
Stock Symbol: NRC
Market: NASDAQ
Website: nrchealth.com

Menu

NRC NRC Quote NRC Short NRC News NRC Articles NRC Message Board
Get NRC Alerts

News, Short Squeeze, Breakout and More Instantly...

NRC - Neuronetics Receives 510(k) Clearance for NeuroSite(TM) Coil Placement Accessory

MALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the U.S. Food and Drug Administrat...

NRC - NeuroStar TMS Receives Expanded Regulatory Approval in Japan

MALVERN, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that the Pharmaceuticals and Medic...

NRC - Ansys enables NuScale Power to develop advanced nuclear technology

2023-11-27 09:49:18 ET More on ANSYS ANSYS, Inc: AI Initiatives Offset By China Restriction Headwind ANSYS: May Still Have Further To Fall BofA lowers Ansys rating to 'underperform' amid China export restrictions Ansys, Materialise partners to enhance additiv...

NRC - Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference

MALVERN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team wil...

NRC - NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced significant updates to the NeuroSt...

NRC - Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced healthcare ...

NRC - National Research Corporation (NRC) Q3 2023 Earnings Call Transcript

2023-11-08 15:11:03 ET National Research Corporation (NRC) Q3 2023 Results Conference Call November 08, 2023 11:00 AM ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants Presentation Operator He...

NRC - National Research GAAP EPS of $0.32, revenue of $37.9M

2023-11-07 17:04:29 ET More on National Research National Research: Economics Well Priced In, Future Value May Be Crimped (Rating Downgrade) Dividend scorecard for National Research Financial information for National Research For further details see: Nati...

NRC - National Research Corporation Announces Third Quarter 2023 Results

LINCOLN, Neb., Nov. 07, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2023. Regarding the Company’s 2023 third quarter, Kevin Karas, Chief Financial Officer, said, “New sales increased compare...

NRC - Neuronetics Reports Third Quarter 2023 Financial and Operating Results

MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with...

Previous 10 Next 10